Critical PDT theory: Viability, cytotoxicity, proliferation and clonogenicity-Is there a difference?

Area of Science:

• Biochemistry and Molecular Biology
• Cell Biology
• Cancer Research

Background:

• Photodynamic therapy (PDT) is a promising cancer treatment modality.
• This study compares two common assays for evaluating PDT efficacy: MTT and clonogenic assays.
• MCF-7c3 breast cancer cells were used as the model system.

Discussion:

• MTT assays measure metabolic activity, while clonogenic assays assess long-term cell reproductive viability.
• Discrepancies between MTT and clonogenic assay results can impact the interpretation of PDT efficacy.
• Understanding these differences is crucial for accurate treatment assessment.

Key Insights:

• Photodynamic therapy efficacy in MCF-7c3 breast cancer cells varied between MTT and clonogenic assays.
• Clonogenic assays provide a more robust measure of long-term treatment effects compared to MTT assays.
• The choice of assay significantly influences the perceived effectiveness of PDT.

Outlook:

• Further validation of PDT efficacy using clonogenic assays is recommended.
• Investigating the impact of different photosensitizers on assay outcomes is warranted.
• Optimizing PDT protocols based on reliable cell survival data is essential for clinical translation.